A Prospective, Interventional, Randomized, Double-blinded, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of Bacillus clausii 088AE as Immunomodulator in Acute Allergic Rhinitis

Published: 21 October 2021| Version 1 | DOI: 10.17632/r28yk274z6.1
Contributors:
,

Description

The proposed study is planned on a spore forming probiotic B. clausii 088AE for its ability to induce immune system by modulating a series of inflammatory markers and immune cells in allergic rhinitis. The present study highlights the efficacy and safety of B. clausii 088AE and demonstrate its immunomodulatory effect in acute allergic rhinitis.

Files

Institutions

Advanced Enzyme Technologies Ltd

Categories

Clinical Trial, Immunotherapy, Allergic Rhinitis, Clinical Trial Results, Probiotic Bacteria

License